Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Page 1
Long-term outcome of patients with frequently recurrent non-muscle-invasive bladder carcinoma treated with one perioperative plus four weekly instillations of mitomycin C followed by monthly bacillus Calmette-Guerin (BCG) or alternating BCG and interferon-alpha2b instillations: prospective randomised FinnBladder-4 study.
Järvinen R, Marttila T, Kaasinen E, Rintala E, Aaltomaa S, Kallio J, Liukkonen T, Puolakka VM, Seppänen M, Tuhkanen K, Vaarala M, Viitanen J, Boström PJ; FinnBladder Group. Järvinen R, et al. Eur Urol. 2015 Oct;68(4):611-7. doi: 10.1016/j.eururo.2015.02.022. Epub 2015 Mar 5. Eur Urol. 2015. PMID: 25748117 Clinical Trial.
BACKGROUND: Recurrent TaT1 non-muscle-invasive bladder cancer (NMIBC) patients should be treated with immediate instillation of chemotherapy after transurethral resection of bladder tumour followed by instillation therapy. OBJECTIVE: To present long-term results of a study …
BACKGROUND: Recurrent TaT1 non-muscle-invasive bladder cancer (NMIBC) patients should be treated with immediate instillation of chemotherapy …
Long-term results of maintenance treatment of mitomycin C or alternating mitomycin C and bacillus Calmette-Guerin instillation therapy of patients with carcinoma in situ of the bladder: a subgroup analysis of the prospective FinnBladder 2 study with a 17-year follow-up.
Järvinen R, Kaasinen E, Rintala E, Group TF. Järvinen R, et al. Scand J Urol Nephrol. 2012 Dec;46(6):411-7. doi: 10.3109/00365599.2012.694906. Epub 2012 Jul 2. Scand J Urol Nephrol. 2012. PMID: 22746387 Clinical Trial.
OBJECTIVE: Only a few studies with a long-term follow-up exist on patients with carcinoma in situ (CIS) treated with instillation therapy. The objective was to study the long-term outcome of patients with CIS after mitomycin C (MMC) monotherapy or alternating therap …
OBJECTIVE: Only a few studies with a long-term follow-up exist on patients with carcinoma in situ (CIS) treated with instillation the …
Long-term efficacy of maintenance bacillus Calmette-Guerin versus maintenance mitomycin C instillation therapy in frequently recurrent TaT1 tumours without carcinoma in situ: a subgroup analysis of the prospective, randomised FinnBladder I study with a 20-year follow-up.
Järvinen R, Kaasinen E, Sankila A, Rintala E; FinnBladder Group. Järvinen R, et al. Eur Urol. 2009 Aug;56(2):260-5. doi: 10.1016/j.eururo.2009.04.009. Epub 2009 Apr 16. Eur Urol. 2009. PMID: 19395154
BACKGROUND: The long-term prospective data on bacillus Calmette-Guerin (BCG) and mitomycin C (MMC) instillation therapy are limited. OBJECTIVE: To compare the long-term benefit of BCG and MMC maintenance therapy in patients with recurrent bladder carcinoma. ...
BACKGROUND: The long-term prospective data on bacillus Calmette-Guerin (BCG) and mitomycin C (MMC) instillation therapy are limited. …
Short-term and long-term reproducibility of dietary history interview data.
Järvinen R, Seppänen R, Knekt P. Järvinen R, et al. Int J Epidemiol. 1993 Jun;22(3):520-7. doi: 10.1093/ije/22.3.520. Int J Epidemiol. 1993. PMID: 8359970 Clinical Trial.
This study gives results for comparisons between dietary history interviews repeated at short-term (4-8 months) and long-term (4-7 years) intervals in conjunction with the Finnish Mobile Clinic Health Examination Survey. Interviews surveying the whole range of consu …
This study gives results for comparisons between dietary history interviews repeated at short-term (4-8 months) and long-term …